Results 251 to 257 of about 46,962 (257)

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Blood, 2012
Hagop M Kantarjian, Michele Baccarani, Jiangxiang Wang   +2 more
exaly  

Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy

Biomaterials, 2015
Jiang Li, Mohammed Y Ghazwani, Wenchen Zhao   +2 more
exaly  

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy

Journal of Controlled Release, 2017
Jingjing Sun, Yanhua Liu, Yichao Chen
exaly  

Senolytics improve physical function and increase lifespan in old age

Nature Medicine, 2018
Ming Xu, Joshua N Farr, Allyson K Palmer
exaly  

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Leukemia, 2008
Andreas Hochhaus
exaly  

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL

Journal of Clinical Oncology
Caterina Ilari, Renato Bassan, Alfonso Piciocchi   +2 more
exaly  

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

Leukemia, 2009
exaly